Inventor · disambiguated record
Peng Dai
Also filed as: DAI PENG
14 granted patents·4 pending applications·41 citations·filing 2011–2024
90Inventor score
Top patents by PatentIndex Score
18 records- 0195US10968249B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 6, 2021·3 cites·12 claims
- 0295US10584145B2Process for preparation of sulfonylurea bile acid derivativesENANTA PHARM INC·Filed 2017·Granted Mar 10, 2020·8 cites·14 claims
- 0393US10696713B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 30, 2020·3 cites·15 claims
- 0492US10208081B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2015·Granted Feb 19, 2019·9 cites·53 claims
- 0591US10457703B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2016·Granted Oct 29, 2019·8 cites·16 claims
- 0689US11718641B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Aug 8, 2023·1 cites·5 claims
- 0789US11040998B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 22, 2021·2 cites·17 claims
- 0888US11958879B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Apr 16, 2024·1 cites·5 claims
- 0987US10472386B2Bile acid derivatives as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Nov 12, 2019·6 cites·10 claims
- 1085US12281140B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2023·Granted Apr 22, 2025·0 cites·8 claims
- 1180US2024327452A1Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use ThereofENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 1262US10947264B2Process for preparation of sulfonylurea bile acid derivativesENANTA PHARM INC·Filed 2020·Granted Mar 16, 2021·0 cites·5 claims
- 1347US10882941B2Initiator mixture, composition, the use thereof, polyol polymer preparation method, and polyol polymer obtained by the methodARKEMA FRANCE·Filed 2016·Granted Jan 5, 2021·0 cites·17 claims
- 1441US10519191B2Bile acid analogs as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2015·Granted Dec 31, 2019·0 cites·13 claims
- 1541US2016176917A1Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use ThereofENANTA PHARM INC·Filed 2015·Application pending·0 cites
- 1640US10364267B2Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Jul 30, 2019·0 cites·15 claims
- 1732US2013012493A1Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their useZHAO HE·Filed 2011·Application pending·0 cites
- 1830US2017298167A1Method for preparing a grafted unsaturated synthetic rubberARKEMA FRANCE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peng Dai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →